| Parameters . | Cases (n = 16) . | Controls (n = 48) . | P . |
|---|---|---|---|
| Median age (interquartile range), y | 54.5 (46.8–65) | 54.5 (46.8–64.8) | .996 |
| Sex, No. (%) | |||
| Male | 13 (81.2) | 39 (81.2) | 1.000 |
| Female | 3 (18.8) | 9 (18.8) | |
| Ethnicity, No. (%) | |||
| Chinese | 15 (93.7) | 44 (91.7) | 1.000 |
| Others | 1 (6.3) | 4 (8.3) | |
| Route of HCV infection, No. (%) | |||
| Intravenous drug use | 8 (50.0) | 25 (52.1) | .107 |
| Blood transfusion before 1991 | 2 (12.5) | 11 (22.9) | |
| Hemophilia | 2 (12.5) | 0 (0.0) | |
| Men who have sex with men | 1 (6.25) | 3 (6.25) | |
| Tattoo | 1 (6.25) | 0 (0.0) | |
| Unknown | 2 (12.5) | 9 (18.75) | |
| Infecting HCV genotype, No. (%) | |||
| Genotype 1: 1a or 1b | 8 (50.0) | 18 (37.5) | .485 |
| Genotype 6 | 5 (31.25) | 19 (39.6) | |
| Other genotypes | 0 (0.0) | 5 (10.4) | |
| Unknown/indeterminate genotype | 3 (18.75) | 6 (12.5) | |
| Known HBsAg positivity, No. (%) | 4 (25.0) | 5 (10.4) | .210 |
| Known HIV positivity, No. (%) | 1 (6.25) | 2 (4.2) | 1.000 |
| Parameters . | Cases (n = 16) . | Controls (n = 48) . | P . |
|---|---|---|---|
| Median age (interquartile range), y | 54.5 (46.8–65) | 54.5 (46.8–64.8) | .996 |
| Sex, No. (%) | |||
| Male | 13 (81.2) | 39 (81.2) | 1.000 |
| Female | 3 (18.8) | 9 (18.8) | |
| Ethnicity, No. (%) | |||
| Chinese | 15 (93.7) | 44 (91.7) | 1.000 |
| Others | 1 (6.3) | 4 (8.3) | |
| Route of HCV infection, No. (%) | |||
| Intravenous drug use | 8 (50.0) | 25 (52.1) | .107 |
| Blood transfusion before 1991 | 2 (12.5) | 11 (22.9) | |
| Hemophilia | 2 (12.5) | 0 (0.0) | |
| Men who have sex with men | 1 (6.25) | 3 (6.25) | |
| Tattoo | 1 (6.25) | 0 (0.0) | |
| Unknown | 2 (12.5) | 9 (18.75) | |
| Infecting HCV genotype, No. (%) | |||
| Genotype 1: 1a or 1b | 8 (50.0) | 18 (37.5) | .485 |
| Genotype 6 | 5 (31.25) | 19 (39.6) | |
| Other genotypes | 0 (0.0) | 5 (10.4) | |
| Unknown/indeterminate genotype | 3 (18.75) | 6 (12.5) | |
| Known HBsAg positivity, No. (%) | 4 (25.0) | 5 (10.4) | .210 |
| Known HIV positivity, No. (%) | 1 (6.25) | 2 (4.2) | 1.000 |
Abbreviations: HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus.
| Parameters . | Cases (n = 16) . | Controls (n = 48) . | P . |
|---|---|---|---|
| Median age (interquartile range), y | 54.5 (46.8–65) | 54.5 (46.8–64.8) | .996 |
| Sex, No. (%) | |||
| Male | 13 (81.2) | 39 (81.2) | 1.000 |
| Female | 3 (18.8) | 9 (18.8) | |
| Ethnicity, No. (%) | |||
| Chinese | 15 (93.7) | 44 (91.7) | 1.000 |
| Others | 1 (6.3) | 4 (8.3) | |
| Route of HCV infection, No. (%) | |||
| Intravenous drug use | 8 (50.0) | 25 (52.1) | .107 |
| Blood transfusion before 1991 | 2 (12.5) | 11 (22.9) | |
| Hemophilia | 2 (12.5) | 0 (0.0) | |
| Men who have sex with men | 1 (6.25) | 3 (6.25) | |
| Tattoo | 1 (6.25) | 0 (0.0) | |
| Unknown | 2 (12.5) | 9 (18.75) | |
| Infecting HCV genotype, No. (%) | |||
| Genotype 1: 1a or 1b | 8 (50.0) | 18 (37.5) | .485 |
| Genotype 6 | 5 (31.25) | 19 (39.6) | |
| Other genotypes | 0 (0.0) | 5 (10.4) | |
| Unknown/indeterminate genotype | 3 (18.75) | 6 (12.5) | |
| Known HBsAg positivity, No. (%) | 4 (25.0) | 5 (10.4) | .210 |
| Known HIV positivity, No. (%) | 1 (6.25) | 2 (4.2) | 1.000 |
| Parameters . | Cases (n = 16) . | Controls (n = 48) . | P . |
|---|---|---|---|
| Median age (interquartile range), y | 54.5 (46.8–65) | 54.5 (46.8–64.8) | .996 |
| Sex, No. (%) | |||
| Male | 13 (81.2) | 39 (81.2) | 1.000 |
| Female | 3 (18.8) | 9 (18.8) | |
| Ethnicity, No. (%) | |||
| Chinese | 15 (93.7) | 44 (91.7) | 1.000 |
| Others | 1 (6.3) | 4 (8.3) | |
| Route of HCV infection, No. (%) | |||
| Intravenous drug use | 8 (50.0) | 25 (52.1) | .107 |
| Blood transfusion before 1991 | 2 (12.5) | 11 (22.9) | |
| Hemophilia | 2 (12.5) | 0 (0.0) | |
| Men who have sex with men | 1 (6.25) | 3 (6.25) | |
| Tattoo | 1 (6.25) | 0 (0.0) | |
| Unknown | 2 (12.5) | 9 (18.75) | |
| Infecting HCV genotype, No. (%) | |||
| Genotype 1: 1a or 1b | 8 (50.0) | 18 (37.5) | .485 |
| Genotype 6 | 5 (31.25) | 19 (39.6) | |
| Other genotypes | 0 (0.0) | 5 (10.4) | |
| Unknown/indeterminate genotype | 3 (18.75) | 6 (12.5) | |
| Known HBsAg positivity, No. (%) | 4 (25.0) | 5 (10.4) | .210 |
| Known HIV positivity, No. (%) | 1 (6.25) | 2 (4.2) | 1.000 |
Abbreviations: HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
